Steroid-free remission in adalimumab-treated pediatric patients with moderately to severely active Crohn's disease in the IMAgINE 1 trial

¹Nationwide Children's Hospital, Columbus, OH, United States, ²The Hospital for Sick Children, Toronto, ON, Canada,³University of Vermont, Burlington, VT, United States, ⁴Université Sorbonne Paris Cité, Hôpital Necker-Enfants Malades, Paris, France, ⁵Mayo Clinic, Rochester, MN, United States, ⁶CT Children's Medical Center, Hartford, CT, United States, ⁷AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany, ⁸AbbVie Inc, North Chicago, IL, USA